Aptorum Group Limited Reports 2020 Fiscal Year End Financial Results and Provides Business Update
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in...
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in...
ATLANTA--(BUSINESS WIRE)--Apr 19, 2021--The Coca-Cola Company today reported first quarter 2021 results and provided an update on progress against its...
GENEVA, SWITZERLAND / ACCESSWIRE / April 15, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"), a biopharmaceutical...
Not long ago Commenced Affected person Enrollment in Period 1/2 CAReS Study of Art27.13 in the British islesNoted Favourable Pre-Medical...
LAS VEGAS, April 9, 2021 /PRNewswire/ -- Allegiant Travel Company (NASDAQ: ALGT) today reported preliminary passenger traffic results for March...
SEATTLE, April 07, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...
MEXICO CITY, April 7, 2021 /PRNewswire/ -- Grupo Aeromexico S.A.B. de C.V. ("Aeromexico") (BMV: AEROMEX) today reported March 2021 operational...
ATLANTA & NEW YORK--(Enterprise WIRE)--Apr 6, 2021--Intercontinental Trade, Inc. (NYSE: ICE), a major global provider of data, technology and market...
Phase 2b dry AMD patient recruitment completed with topline data expected Q2 2022NDA submission for elamipretide for cardiomyopathy in Barth...
Charlie's PMTA is in Substantive Review with the FDAQ4 Showed 15% Increase in Quarterly RevenueCOSTA MESA, CA / ACCESSWIRE /...
WINDOW ROCK, Ariz. — The Navajo Nation on Saturday reported 18 additional confirmed COVID-19 cases and four more deaths.The pandemic...
Implements new corporate strategy to focus on precision therapeutics for the treatment of cancer Strengthens pipeline by acquiring a proprietary...
Plans to have three AAV gene therapy programs in the clinic by year-end 2021Data from FLT180a Phase 1/2 trial for...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 1, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...
Clinical evaluation of AM-301 nasal spray in allergen protection progressingLaunch of AM-301 expected in selected markets towards the end of...
Enrollment complete for Saturn-1, first TP-03 pivotal trial for the treatment of Demodex blepharitis; initiation of Saturn-2 expected in Q2...
TipRanks2 “Strong Buy” Penny Stocks That Could Go GrowthArguably the most controversial on the Street, penny shares are a very...
WARRINGTON, Pa., March 29, 2021 /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on...